StayOK - an Innovative Measuring Instrument for the Early Identification and Treatment of Psychosocial Risks

Sponsor
Zurich University of Applied Sciences (Other)
Overall Status
Completed
CT.gov ID
NCT03213327
Collaborator
Health and Medical Services (Other), Helsana (Other), Neomentum (Other), Sanatorium Kilchberg AG (Other), Design your life (Other)
174
1
1
24.7
7.1

Study Details

Study Description

Brief Summary

The validity and the sensitivity of different measures implemented in the web application StayOk are investigated. The measures are used primarily for the assessment and the early identification of psychosocial risks. Secondarily, the results of the assessment are applied to generate health-promoting advices for the user of the web application.

Condition or Disease Intervention/Treatment Phase
  • Device: StayOk web application
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
174 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Patients are examined at two time points: baseline and 12 weeks after the Intervention. The Intervention consists of health-promoting advices provided by the software algorithm. The effect of this intervention is evaluated 12 weeks after.Patients are examined at two time points: baseline and 12 weeks after the Intervention. The Intervention consists of health-promoting advices provided by the software algorithm. The effect of this intervention is evaluated 12 weeks after.
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
StayOK - an Innovative Measuring Instrument for the Early Identification and Treatment of Psychosocial Risks
Actual Study Start Date :
Jul 10, 2017
Actual Primary Completion Date :
Jul 31, 2019
Actual Study Completion Date :
Jul 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Other: Case management

Case management program Utilization of the StayOk web application

Device: StayOk web application
Patients fill in the questionnaires of the web application and receive an analyzed profile of their psychosocial condition and health-promoting advices

Outcome Measures

Primary Outcome Measures

  1. Psychological distress [0 week (first assessment)]

    The psychological distress is assessed by the Brief Symptom Inventory (BSI; Derogatis & Melisaratos, 1983)

  2. Work-related sense of coherence [0 weeks]

    The work-related sense of coherence is assessed by the Work Sense of Coherence (W-SoC 9; Jenny et al., 2016)

  3. Perceived self-efficacy [0 weeks]

    This aspect is measure by the General Self-Efficacy Scale (GSE; Damásio et al., 2016)

Secondary Outcome Measures

  1. Effectiveness of health-promoting advices [12 weeks after the first assessment]

    The effectiveness of the advices generated by the software is assessed by means of a self-developed questionnaire: Participants are inquired as to (1) whether they put in practice the advices and (2) how they evaluate the benefit of the applied advices and the consequent satisfaction.

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • at 16 years of age

  • mild to moderate psychological distress

Exclusion Criteria:
  • serious cognitive impairment due to dementia or cerebrovascular insult

  • Insufficient knowledge of one of the following languages: German, French, Italian or English

Contacts and Locations

Locations

Site City State Country Postal Code
1 Helsana Zürich Switzerland

Sponsors and Collaborators

  • Zurich University of Applied Sciences
  • Health and Medical Services
  • Helsana
  • Neomentum
  • Sanatorium Kilchberg AG
  • Design your life

Investigators

  • Principal Investigator: Agnes von Wyl, Prof, Zurich University of Applied Sciences

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Aureliano Crameri, Dr. phil., Zurich University of Applied Sciences
ClinicalTrials.gov Identifier:
NCT03213327
Other Study ID Numbers:
  • BASEC-Nr. 2016-00879
First Posted:
Jul 11, 2017
Last Update Posted:
Jun 23, 2020
Last Verified:
Jun 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Aureliano Crameri, Dr. phil., Zurich University of Applied Sciences
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 23, 2020